Raleigh Radiology Blue Ridge had previously halted all mammography exams after an ACR and FDA review found technical quality issues in a set of its images.

The grant will go toward the Duke Radiation Oncology and Radiology Stimulating Access to Research in Residency program, which pairs students with professors on the cutting edge of the university's medical research.

“This pioneering effort leverages evidence-based guidelines and the consensus of medical experts in a new and powerful way to optimize care for military veterans,” said Theodore L. DeWeese, MD, chair of ASTRO's board.

The Ad Hoc Group for Medical Research, which includes the American College of Radiology and Society of Nuclear Medicine and Molecular Imaging, is pushing for a bump to the institute's budget.

The House Ways & Means Committee unveiled its proposal earlier this month, which includes a mediation process that does not exclude providers based on an established qualifying threshold.

“We’ve flipped the concept from having to get patients to the MRI to bringing the MRI to the patients,” said senior author of the preliminary research, Kevin Sheth, MD.

Idaho-based International Isotopes has received U.S. Food and Drug Administration approval for its radioactive therapeutic agent used to treat thyroid cancers.

The National Institute on Aging awarded Wake Forest School of Medicine a five-year grant to examine if a novel PET tracer can help researchers tackle the disease.

Caption Guidance works with ultrasound software previously cleared by the FDA to help inexperienced clinicians acquire transthoracic echocardiography images.

The Florida-based orthopedic surgeon filed a whistleblower lawsuit against Orlando Health, claiming he was fired for not referring patients to in-network imaging practices and performing surgeries at out-of-network facilities.

Researchers analyzed chargemasters and websites for the top-20 ranked U.S. academic hospitals and determined most are doing the bare minimum to offer digestible pricing information to patients.

Officials noted that the product line is no longer seen as a "strategic fit" for the Amsterdam-based company.